Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Interleukin Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Interleukin Inhibitorsmarket, defines the market attractiveness level of Interleukin Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Interleukin Inhibitors industry, describes the types of Interleukin Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Interleukin Inhibitors market and the development prospects and opportunities of Interleukin Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Interleukin Inhibitors market in Chapter 13.
By Player:
Roche
Teva Pharmaceutical
AstraZeneca
Sanofi
Eli Lilly
Valeant Pharmaceuticals
Johnson & Johnson
Novartis
Regeneron Pharmaceuticals
GlaxoSmithKline
By Type:
IL-17
IL-23
IL-1
IL-5
IL-6
Others
By End-User:
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Asthma
Inflammatory Bowel Disease (IBD)
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Interleukin Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Interleukin Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Interleukin Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Interleukin Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Interleukin Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Interleukin Inhibitors Consumption (2017-2022)
-
7.2 United States Interleukin Inhibitors Consumption (2017-2022)
-
7.3 Europe Interleukin Inhibitors Consumption (2017-2022)
-
7.4 China Interleukin Inhibitors Consumption (2017-2022)
-
7.5 Japan Interleukin Inhibitors Consumption (2017-2022)
-
7.6 India Interleukin Inhibitors Consumption (2017-2022)
-
7.7 South Korea Interleukin Inhibitors Consumption (2017-2022)
8 Region and Country-wise Interleukin Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Interleukin Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Interleukin Inhibitors Consumption Forecast (2022-2028)
9 Global Interleukin Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Interleukin Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global IL-17 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global IL-23 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global IL-1 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global IL-5 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global IL-6 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Interleukin Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Interleukin Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Interleukin Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global IL-17 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global IL-23 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global IL-1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global IL-5 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global IL-6 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Interleukin Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Interleukin Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Interleukin Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Interleukin Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Interleukin Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Interleukin Inhibitors Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Interleukin Inhibitors Product and Service
-
14.2 Teva Pharmaceutical
-
14.2.1 Teva Pharmaceutical Company Details
-
14.2.2 Teva Pharmaceutical Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Interleukin Inhibitors Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Interleukin Inhibitors Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Interleukin Inhibitors Product and Service
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Details
-
14.5.2 Eli Lilly Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly Interleukin Inhibitors Product and Service
-
14.6 Valeant Pharmaceuticals
-
14.6.1 Valeant Pharmaceuticals Company Details
-
14.6.2 Valeant Pharmaceuticals Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Valeant Pharmaceuticals Interleukin Inhibitors Product and Service
-
14.7 Johnson & Johnson
-
14.7.1 Johnson & Johnson Company Details
-
14.7.2 Johnson & Johnson Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson & Johnson Interleukin Inhibitors Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Interleukin Inhibitors Product and Service
-
14.9 Regeneron Pharmaceuticals
-
14.9.1 Regeneron Pharmaceuticals Company Details
-
14.9.2 Regeneron Pharmaceuticals Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Regeneron Pharmaceuticals Interleukin Inhibitors Product and Service
-
14.10 GlaxoSmithKline
-
14.10.1 GlaxoSmithKline Company Details
-
14.10.2 GlaxoSmithKline Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline Interleukin Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Interleukin Inhibitors
-
Figure Interleukin Inhibitors Picture
-
Table Global Interleukin Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Interleukin Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Interleukin Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Interleukin Inhibitors Consumption by Country (2017-2022)
-
Figure United States Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IL-17 Consumption and Growth Rate (2017-2022)
-
Figure Global IL-23 Consumption and Growth Rate (2017-2022)
-
Figure Global IL-1 Consumption and Growth Rate (2017-2022)
-
Figure Global IL-5 Consumption and Growth Rate (2017-2022)
-
Figure Global IL-6 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global IL-17 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IL-23 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IL-1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IL-5 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IL-6 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Interleukin Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Interleukin Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Interleukin Inhibitors Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Interleukin Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Interleukin Inhibitors Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Interleukin Inhibitors Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Interleukin Inhibitors Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Interleukin Inhibitors Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Interleukin Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Interleukin Inhibitors Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Interleukin Inhibitors Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Interleukin Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Interleukin Inhibitors Product and Service
-
